Marchetto S - Search Results

1

Mechanisms of acute and chronic hypoglycemic action of gliclazide.

da Tos V, Maran A, Vigili de Kreutzenberg S, Marchetto S, Tadiotto F, Bettio M, Marescotti MC, Tiengo A, Del Prato S. da Tos V, et al. Among authors: marchetto s. Acta Diabetol. 2000;37(4):201-6. doi: 10.1007/s005920070006. Acta Diabetol. 2000. PMID: 11450504 Clinical Trial.

2

Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.

Riccio A, Lisato G, de Kreutzenberg SV, Marchetto S, Turrin M, Tiengo A, Del Prato S. Riccio A, et al. Among authors: marchetto s. Metabolism. 1996 Oct;45(10):1196-202. doi: 10.1016/s0026-0495(96)90235-8. Metabolism. 1996. PMID: 8843172 Clinical Trial.

3

Metformin and free fatty acid metabolism.

Del Prato S, Marchetto S, Pipitone A, Zanon M, Vigili de Kreutzenberg S, Tiengo A. Del Prato S, et al. Among authors: marchetto s. Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S33-41. doi: 10.1002/dmr.5610110506. Diabetes Metab Rev. 1995. PMID: 8529483 Review. No abstract available.

4

Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition.

de Kreutzenberg SV, Crepaldi C, Marchetto S, Calò L, Tiengo A, Del Prato S, Avogaro A. de Kreutzenberg SV, et al. Among authors: marchetto s. J Clin Endocrinol Metab. 2000 Feb;85(2):793-8. doi: 10.1210/jcem.85.2.6352. J Clin Endocrinol Metab. 2000. PMID: 10690892

5

Real-world study on the effectiveness and safety of basal insulin IDegLira in type 2 diabetic patients previously treated with multi-injective insulin therapy.

Persano M, Nollino L, Sambataro M, Rigato M, Negro I, Marchetto S, Paccagnella A. Persano M, et al. Among authors: marchetto s. Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):923-931. doi: 10.26355/eurrev_202101_24661. Eur Rev Med Pharmacol Sci. 2021. PMID: 33577047 Free article.

6

[Group educational intervention in diabetic foot: the objectives, pedagogical strategies, level of knowledge and results].

Monesi G, Marchetto S, Chiarion L, Manunta R, Stievano A, Perari D, Lippi C, Mollo F, Lisato G. Monesi G, et al. Among authors: marchetto s. Riv Inferm. 1992 Apr-Jun;11(2):81-8. Riv Inferm. 1992. PMID: 1502441 Italian.

7

[The education tree. Experiences from one century of anti-diabetic treatment].

Marchetto S, Perari D, Bolzoni MO, Chiarion L, Gabriele MS, Milan P, Nalin K, Osti E, Pavarin A, Strenghetto L, Monesi G. Marchetto S, et al. Riv Inferm. 1997 Oct-Dec;16(4):215-8. Riv Inferm. 1997. PMID: 9510824 Italian.

8

Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.

Rischio and Prevenzione Investigators. Rischio and Prevenzione Investigators. Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68. Trials. 2010. PMID: 20509875 Free PMC article. Clinical Trial.

9

[Nurse-patient communication concerning the education of the diabetic patient: revision of a protocol].

Marchetto S, Perari D, Monesi G. Marchetto S, et al. Assist Inferm Ric. 1999 Apr-Jun;18(2):65-71. Assist Inferm Ric. 1999. PMID: 10909328 Italian.

10

[Organization of an antidiabetic center].

Bedendo M, Marchetto S, Stievano A. Bedendo M, et al. Among authors: marchetto s. Riv Inferm. 1986 Dec;5(4):208-16. Riv Inferm. 1986. PMID: 3110911 Italian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters